Literature DB >> 20308235

The neurofibromatoses.

Rosalie E Ferner.   

Abstract

Neurofibromatosis 1 (NF1) and neurofibromatosis 2 (NF2) are inherited autosomal dominant disorders that have a significant impact on the nervous system and predispose to tumour formation. The current nomenclature makes NF1 and NF2 awkward bedfellows because they are clinically and genetically separate disorders. Neurofibromas are characteristic of NF1, a common condition with major skin involvement and many clinical complications. By contrast, schwannomas are the distinctive lesions in NF2, cutaneous signs are less prominent in this rarer disorder and clinical manifestations are largely restricted to the nervous system and eye. The current aim of neurofibromatosis specialists is to provide cohesive standards of care for everyone with neurofibromatosis and to devise standardised protocols for assessment and management within a multidisciplinary setting.

Entities:  

Mesh:

Year:  2010        PMID: 20308235     DOI: 10.1136/jnnp.2010.206532

Source DB:  PubMed          Journal:  Pract Neurol        ISSN: 1474-7758


  32 in total

Review 1.  Vestibular schwannoma in a patient with neurofibromatosis type 1: clinical report and literature review.

Authors:  Aamira Huq; Maira Kentwell; Amanda Tirimacco; Jacqueline Rossini; Lesley Rawlings; Ingrid Winship
Journal:  Fam Cancer       Date:  2015-03       Impact factor: 2.375

2.  The Impact of Neurofibromatosis Type 1 on the Health and Wellbeing of Australian Adults.

Authors:  Hilda A Crawford; Belinda Barton; Meredith J Wilson; Yemima Berman; Valerie J McKelvey-Martin; Patrick J Morrison; Kathryn N North
Journal:  J Genet Couns       Date:  2015-04-19       Impact factor: 2.537

Review 3.  Coincident liposarcoma, carcinoid and gastrointestinal stromal tumor complicating type 1 neurofibromatosis: Case report and literature review.

Authors:  Aaron W James; Le Chang; Scott Genshaft; Sarah M Dry
Journal:  J Orthop       Date:  2014-11-26

4.  Early Genetic Diagnosis of Neurofibromatosis Type 2 From Skin Plaque Plexiform Schwannomas in Childhood.

Authors:  Elisabeth Castellanos; Adrià Plana; Cristina Carrato; Meritxell Carrió; Inma Rosas; Emilio Amilibia; Francesc Roca-Ribas; Cristina Hostalot; Alicia Castillo; Andrea Ros; Ariadna Quer; Juan Luis Becerra; Hector Salvador; Conxi Lázaro; Ignacio Blanco; Eduard Serra; Isabel Bielsa
Journal:  JAMA Dermatol       Date:  2018-03-01       Impact factor: 10.282

5.  Therapeutics for childhood neurofibromatosis type 1 and type 2.

Authors:  Simone L Ardern-Holmes; Kathryn N North
Journal:  Curr Treat Options Neurol       Date:  2011-12       Impact factor: 3.598

Review 6.  CT and MRI of superficial solid tumors.

Authors:  Jingfeng Zhang; Yanyuan Li; Yilei Zhao; Jianjun Qiao
Journal:  Quant Imaging Med Surg       Date:  2018-03

Review 7.  The pathoetiology of neurofibromatosis 1.

Authors:  Eeva-Mari Jouhilahti; Sirkku Peltonen; Anthony M Heape; Juha Peltonen
Journal:  Am J Pathol       Date:  2011-03-31       Impact factor: 4.307

Review 8.  Modeling cognitive dysfunction in neurofibromatosis-1.

Authors:  Kelly A Diggs-Andrews; David H Gutmann
Journal:  Trends Neurosci       Date:  2013-01-08       Impact factor: 13.837

Review 9.  Familial syndromes associated with intracranial tumours: a review.

Authors:  Adrianna M Ranger; Yatri K Patel; Navjot Chaudhary; Ram V Anantha
Journal:  Childs Nerv Syst       Date:  2013-11-06       Impact factor: 1.475

10.  Neurofibromatosis: types 1 and 2.

Authors:  S Borofsky; L M Levy
Journal:  AJNR Am J Neuroradiol       Date:  2013-04-18       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.